ACXP Acurx Pharmaceuticals, Inc.

Fundamentals / CIK 0001736243 / USD

Acurx Pharmaceuticals, Inc. reported $10.34M in total assets and a net loss of $8.10M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACXP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$13.63MFY 2020 Net Income: -$4.60M2020FY 2021 Net Income: -$12.75M2021FY 2022 Net Income: -$12.09M2022FY 2023 Net Income: -$14.58M2023FY 2024 Net Income: -$14.10M2024FY 2025 Net Income: -$7.97M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $1.83M $5.40M $6.04M $4.75M $2.03M $2.20M
Selling, General & Admin -- -- -- -- $208K --
Total Operating Expenses $8.09M $14.12M $14.58M $12.09M $12.81M $4.60M
Operating Income -$8.09M -$14.12M -- -- -- --
Interest Income $125K $20K -- -- -- --
Income Tax Expense -- -- -- $0 -- $0
Net Income -$7.97M -$14.10M -$14.58M -$12.09M -$12.75M -$4.60M
Basic EPS -$5.32 -$17.45 -$23.00 -$22.40 -$29.80 -$14.80
Diluted EPS -$5.32 -$17.45 -$23.00 -$22.40 -$29.80 -$14.80
Basic Shares Outstanding 1.5M 808.2K 633.6K 540.8K 426.8K 309.5K
Diluted Shares Outstanding 1.5M 808.2K 633.6K 540.8K 426.8K 309.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.12M $1.07M $341K $282K $430K $524K $599K $825K
Total Operating Expenses $2.63M $2.31M $1.72M $1.62M $2.03M $2.27M $2.18M $2.79M
Operating Income -$2.63M -$2.31M -$1.72M -$1.62M -$2.03M -$2.27M -$2.18M --
Interest Income $48K $53K $35K $39K $36K $23K $27K --
Net Income -$2.58M -$2.25M -$1.68M -$1.58M -$1.99M -$2.25M -$2.15M -$2.78M
Basic EPS -$0.49 -$0.53 -$0.62 -- -$1.23 -$1.89 -$2.15 --
Diluted EPS -$0.49 -$0.53 -$0.62 -- -$1.23 -$1.89 -$2.15 --
Basic Shares Outstanding 5.3M 4.3M 2.7M -- 1.6M 1.2M 1.0M --
Diluted Shares Outstanding 5.3M 4.3M 2.7M -- 1.6M 1.2M 1.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.56M $3.71M $7.47M $9.11M $12.96M $3.18M
Cash & Short-Term Investments $7.56M $3.71M $7.47M $9.11M $12.96M $3.18M
Total Current Assets -- $3.86M $7.71M $9.38M $13.25M --
Total Non-Current Assets -- $0 $0 $0 $0 --
Total Assets $7.69M $3.86M $7.71M $9.38M $13.25M $3.22M
Total Current Liabilities $2.42M $3.24M $3.04M $2.06M $844K $473K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $50K
Total Liabilities $2.42M $3.24M $3.04M $2.06M $844K $522K
Common Stock $2.3K $852 $14K $12K $10K --
Retained Earnings -$75.29M -$67.32M -$53.22M -$38.64M -$26.55M -$13.80M
Total Stockholders' Equity $5.27M $615K $4.67M $7.32M $12.41M $2.70M
Total Equity $5.27M $615K $4.67M $7.32M $12.41M $2.70M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31 2024-06-30 2024-03-31
Cash & Cash Equivalents $9.65M $10.66M $9.25M $7.56M $5.91M $3.71M $6.36M $8.92M
Cash & Short-Term Investments $9.65M $10.66M $9.25M $7.56M $5.91M $3.71M $6.36M $8.92M
Total Current Assets -- -- -- -- -- $3.86M -- --
Total Non-Current Assets -- -- -- -- -- $0 -- --
Total Assets $10.34M $10.98M $9.54M $7.69M $6.11M $3.86M $6.58M $9.11M
Total Current Liabilities $2.99M $2.83M $2.53M $2.42M $2.47M $3.24M $3.15M $3.11M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $2.99M $2.83M $2.53M $2.42M $2.47M $3.24M $3.15M $3.11M
Common Stock $5.9K $4.7K $3.4K $2.3K $1.8K $852 $16K $16K
Retained Earnings -$81.81M -$79.22M -$76.97M -$75.29M -$73.71M -$67.32M -$61.72M -$57.60M
Total Stockholders' Equity $7.34M $8.15M $7.01M $5.27M $3.64M $615K $3.43M $6.00M
Total Equity $7.34M $8.15M $7.01M $5.27M $3.64M $615K $3.43M $6.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$7.97M -$14.10M -$14.58M -$12.09M -$12.75M -$4.60M
Stock-Based Compensation $1.25M $2.60M $3.21M $2.87M $5.15M $696K
Operating Cash Flow -$6.79M -$10.38M -$9.80M -$7.54M -$5.01M -$3.35M
Common Stock Issued -- -- -- $3.70M -- --
Financing Cash Flow $10.64M $6.62M $8.16M $3.70M $14.80M $4.04M
Net Change in Cash $3.85M -$3.77M -$1.64M -$3.85M $9.78M $692K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.58M -$2.25M -$1.68M -$1.58M -$1.99M -$2.25M -$2.15M -$2.78M
Stock-Based Compensation $208K $201K $258K $295K $295K $324K $334K $345K
Operating Cash Flow -$2.49M -$1.71M -$1.41M -$1.18M -$1.88M -$1.67M -$2.05M -$2.25M
Financing Cash Flow $1.49M $3.11M $3.11M $2.83M $1.72M $3.09M $2.99M $195K
Net Change in Cash -$1.00M $1.40M $1.70M $1.65M -$157K $1.42M $937K -$2.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -151.2% -2292.7% -312.4% -165.3% -102.7% -170.3%
Return on Assets (ROA) -103.6% -365.6% -189.1% -129.0% -96.2% -142.7%
Current Ratio -- 1.19x 2.53x 4.55x 15.71x --
Quick Ratio 3.12x 1.14x 2.46x 4.42x 15.36x 6.72x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -110.3% -92.1% -106.9% -151.2% -252.1% -- -- -2292.7%
Return on Assets (ROA) -78.3% -68.3% -78.6% -103.6% -150.2% -- -- -365.6%
Current Ratio -- -- -- -- -- -- -- 1.19x
Quick Ratio 3.23x 3.76x 3.66x 3.12x 2.39x -- -- 1.14x
Source: SEC EDGAR CompanyFacts (CIK 0001736243) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal